CN Stock MarketDetailed Quotes

688073 Bide Pharmatech

Watchlist
  • 33.43
  • +1.10+3.40%
Market Closed Apr 26 15:00 CST
3.04BMarket Cap30.78P/E (TTM)

Bide Pharmatech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bide Pharmatech Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

262.67M

+4.05%
EPS(YoY)

0.29

-29.27%
Analyst Rating

Strong Buy

Apr 28, 2024

Bide Pharmatech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.984B--
--2024/FY-- / 1.498B--
--2023/FY1.092B / 1.131B--
--2022/FY833.832M / 829.160M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.984B--
--2024/FY-- / 1.498B--
--2023/FY1.092B / 1.131B--
--2022/FY833.832M / 829.160M--

Bide Pharmatech Earnings Reports

  • Summary of Bide Pharma's 2023 Annual Report

    Apr 26 00:00

  • 2023 ANNUAL REPORT

    Apr 26 00:00

  • 2024 First Quarter Report

    Apr 26 00:00

  • 2023 Annual Results Report Announcement

    Feb 3 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Strong Buy

    • Strong Buy

      72.73%

    • Buy

      27.27%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg